Centre Hospitalier Universitaire de Saint Etienne
chu-st-etienne.frLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
593
Active
130
Phase 3
25
Total enrollment
872,754
Pipeline matrix
Showing 32 of 32 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Adalimumab | — | — | — | — | — | 2 | |
| Vedolizumab | — | — | — | — | — | 2 | |
| Clinical tapering strategy | — | — | — | — | — | 1 | |
| Step Wedge trial | — | — | — | — | — | 1 | |
| Biological tests | — | — | — | — | — | 1 | |
| Flu Vaccine | — | — | — | — | — | 1 | |
| Biological samples | — | — | — | — | — | 1 | |
| Early intervention | — | — | — | — | — | 1 | |
| Delayed intervention | — | — | — | — | — | 1 | |
| Full-dose anticoagulant therapy | — | — | — | — | — | 1 | |
| Antiplatelet therapy | — | — | — | — | — | 1 | |
| Rituximab | — | — | — | — | — | 1 | |
| Premedications | — | — | — | — | — | 1 | |
| Hydroxychloroquine | — | — | — | — | 3 | ||
| CAR-T cells | — | — | — | — | — | 1 | |
| BCMA bispecific | — | — | — | — | — | 1 | |
| Mupirocin | — | — | — | — | — | 1 | |
| blood samples after Single dose part | — | — | — | — | — | 1 | |
| Blood sample | — | — | — | 13 | |||
| Blood samples | — | — | — | — | 5 | ||
| Apixaban | — | — | — | — | 2 | ||
| Urinary sample | — | — | — | — | — | 2 | |
| Genotyping | — | — | — | — | — | 1 | |
| Venous sampling | — | — | — | — | — | 1 | |
| Antibiotic treatment | — | — | — | — | — | 1 | |
| Intracellular reservoir test | — | — | — | — | — | 1 | |
| Thrombin Generation Assay | — | — | — | — | — | 1 | |
| Blood collection before antiplatelet treatment | — | — | — | — | — | 1 | |
| Blood collection after antiplatelet treatment | — | — | — | — | — | 1 | |
| Blood samples for PK | — | — | — | — | — | 1 | |
| ceftazidime | — | — | — | — | — | 1 | |
| plasma ceftazidime dosage | — | — | — | — | — | 1 |
Next readouts
- 2025-03-04
- 2025-11
- 2025-12-19
- 2026-01
- 2026-01-01
- 2026-06
- 2026-06-01
- 2026-08-01
- 2026-09-19
- 2026-11
Top conditions
- Healthy23
- Healthy Volunteers12
- Cancer11
- Aging11
- Stroke9
- Schizophrenia8
- Neuropathic Pain8
- Anorexia Nervosa7
Frequently asked questions about Centre Hospitalier Universitaire de Saint Etienne
- How many clinical trials does Centre Hospitalier Universitaire de Saint Etienne have on ClinicalTrials.gov?
- Centre Hospitalier Universitaire de Saint Etienne is listed as the lead sponsor on 593 clinical trials in ClinicalTrials.gov, 130 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Centre Hospitalier Universitaire de Saint Etienne's trials are in Phase 3?
- 25 of Centre Hospitalier Universitaire de Saint Etienne's trials are in Phase 3, spread across 32 active drug programs.
- What therapeutic areas does Centre Hospitalier Universitaire de Saint Etienne focus on?
- Centre Hospitalier Universitaire de Saint Etienne's most-studied conditions on ClinicalTrials.gov are Healthy, Healthy Volunteers, Cancer, Aging, Stroke.
- When are Centre Hospitalier Universitaire de Saint Etienne's next clinical trial readouts?
- Centre Hospitalier Universitaire de Saint Etienne has 10 upcoming primary-completion readouts tracked here; the soonest is “Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study”, expected around 2025-03-04.